World Journal of Dentistry

Register      Login

VOLUME 7 , ISSUE 2 ( April-June, 2016 ) > List of Articles

RESEARCH ARTICLE

Antiangiogenic Therapy in Oral Cancer: A Thoughtful Consideration

Citation Information : Antiangiogenic Therapy in Oral Cancer: A Thoughtful Consideration. World J Dent 2016; 7 (2):51-53.

DOI: 10.5005/jp-journals-10015-1363

Published Online: 00-06-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Sarode GS, Sarode SC, Patil S. Antiangiogenic Therapy in Oral Cancer: A Thoughtful Consideration. World J Dent 2016;7(2):51-53.


PDF Share
  1. A new classification for potentially malignant disorders of the oral cavity. Oral Oncol 2011 Sep;47(9):920-921.
  2. Oral potentially malignant disorders: precising the definition. Oral Oncol 2012 Sep;48(9):759-760.
  3. Accept and respect the uniqueness of oral cancer. World J Dent 2014 Aug;5(4):v-vi.
  4. Is oral cancer unique in terms of chemotherapeutic and targeted drug metabolism? J Oral Maxillofac Surg 2015 Jan;73(1):4-6.
  5. Personalized medicine: the future of cancer treatment. World J Dent 2014;3:v–vi.
  6. Aiming targeted therapy in oral cancer. J Dent Res Rev 2014;2:1
  7. Therapeutic aspects of the inflammation mediated oral carcinogenesis. Oral Oncol 2014 Apr;50(4):e13-14.
  8. Inflammation and oral cancer: an update review on targeted therapies. J Contemp Dent Pract 2015 Jul;16(7):595-602.
  9. The biology of VEGF and its receptors. Nat Med 2003 Jun;9(6):669-676.
  10. Micro RNA in oral cancer research: Future prospects. J Contemp Dent Pract 2014 Sep;15(5):1-2.
  11. Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol Sci 2008 Jan;29(1):12-15.
  12. MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS One 2011 Feb;6(2):e16979.
  13. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 2012 Aug;107;700-706.
  14. MicroRNA-17, 20a regulates the proangiogenic function of tumor-associated macrophages via targeting hypoxia-inducible factor 2a. PLoS One 2013;8(10):e77890
  15. E6 oncoprotein interaction with paxillin and FAK. Oral Oncol 2014 Apr;50(4):e17.
  16. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene 2000;19(40):4611-4620.
  17. Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein induced HIF-1ƒ¿, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells. PLoS One 2014 Jul;9(7):e103440.
  18. E6 and E7 interactions with micro-RNA. Oral Oncol 2014 Aug;50(8):e46-47.
  19. Regulation of cellular miRNA expression by human papillomaviruses. Biochimica et Biophysica Acta (BBA) -Gene Regulatory Mechanisms 2011 Nov-Dec;1809(11):668-677.
  20. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Brit J Cancer 2011 Mar;104(5):830-840.
  21. Psychological intervention in head and neck cancer: from molecular standpoint. World J Dent 2014;5(4):249-250.
  22. Chronic stress and oral cancer research: disregarded aspects in animal model studies. Oral Oncol 2016 Mar;54:e5-e6.
  23. Biobehavioral influences on cancer progression. Immunol Allergy Clin North Am 2011 Feb;31(1):109-132.
  24. Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer. Head Neck 2014 Aug;36(8):1113-1119.
  25. Complex cannibalism: an unusual feature in oral squamous cell carcinoma. Oral Oncol 2012 Feb;48(2):e4-e6.
  26. Endocytosis of keratinocytes in oral squamous cell carcinoma: expression of phagocytic markers. Translational Res Oral Oncol DOI: 10.1177/2057178X15618551.
  27. Neutrophil-tumor cell cannibalism in oral squamous cell carcinoma. J Oral Pathol Med 2014 Jul;43(6):454-458.
  28. Junk DNA: Prospects for oral cancer research. J Contemp Dent Pract 2016 Mar;17(3):1-2.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.